Evidence map›Paper›PMID 26264897›Full record

ReviewSchmerz (Berlin, Germany)2015

[Neuropathic pain. How to open the blackbox].

C Maier, R Baron, C Sommer

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Schmerz (Berlin, Germany), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03210766 (Nabilone and THC/CBD for the Treatment of FBSS Refractory Pain), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03210766 completednot on this map

Nabilone and THC/CBD for the Treatment of FBSS Refractory Pain

TypeobservationalSponsorAzienda Ospedaliera Universitaria Policlinico "G. Martino"Ran2014 to 2016Enrolled20ConditionsFBSSArmsNabilone, THC/CBD
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

C MaierAbteilung für Schmerzmedizin, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH, Bürkle-de-la-Camp Platz 1, 44789, Bochum, Deutschland. christoph.maier@rub.de.
R BaronSektion Schmerzforschung und -therapie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Deutschland.
C SommerNeurologische Klinik, Universitätsklinikum Würzburg, Würzburg, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article, without presuming to be comprehensive, gives a brief outline of the development of research on neuropathic pain in Germany. Current clinical research on this subject focusses on the validation of human models, patient phenotyping, mechanism-based classification and treatment as well as on molecular pathomechanisms. This clinical research is based to a large extent on the work of several internationally recognized basic researchers in the 1990s. In particular, findings from system physiology led to the analysis of clinical phenotypes and the underlying pathophysiology. In parallel, basic research achieved international top levels through the development of innovative methods. Close cooperation, building of consortia and European networking made major contributions to the success of this research.

Indexed as

AnimalsCerebral CortexDisease Models, AnimalForecastingGermanyHumansNeuralgiaNeuronal PlasticityNociceptorsPain ManagementPeripheral Nervous SystemQuality Assurance, Health CareTranslational Research, BiomedicalMechanism-based treatmentModels, animalNeuroinflammationSystems physiologyTranslational medical research

Identifiers

PMID26264897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.